Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-10-01 | New | $1,750,000 | $1,750,000 | Debt Only | 06b | SEC link |
| 2019-07-12 | New | $2,500,000 | $2,500,000 | Other | 06b | SEC link |
| 2017-09-12 | New | $3,000,000 | $3,000,000 | Debt Only | 06b | SEC link |
| 2016-11-08 | New | $3,000,000 | $3,000,000 | Debt Only | 06b | SEC link |
| 2016-04-27 | New | $6,000,000 | $6,000,000 | Other | 06b | SEC link |
| 2015-03-03 | New | $3,500,000 | $3,500,000 | Equity Only | 06b | SEC link |
| 2014-08-13 | New | $607,440 | $607,440 | Equity Only | 06b | SEC link |
| 2013-07-12 | Amended | $3,978,957 | $795,520 | Equity Only | 06 | SEC link |
| 2013-04-29 | Amended | $3,183,437 | $729,166 | Equity Only | 06 | SEC link |
| 2012-05-14 | Amended | $2,454,271 | $347,265 | Equity Only | 06 | SEC link |
| 2012-05-14 | Amended | $2,454,271 | $0 | Equity Only | 06 | SEC link |
| 2012-05-14 | Amended | $2,454,271 | $0 | Equity Only | 06 | SEC link |
| 2012-05-14 | Amended | $2,454,271 | $0 | Equity Only | 06 | SEC link |
| 2011-09-14 | Amended | $2,107,006 | $1,112,001 | Equity Only | 06 | SEC link |
| 2009-10-20 | New | $995,005 | $995,005 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Clarke Atwell | Director |
| Shenda Baker | Director, Executive |
| Daniel Bradbury | Director |
| Robert Coughlin | Director |
| Keiki Pua Dancil | Executive |
| Kenton Gregory | Director |
| Kenton Gregory, M.D. | Director |
| Paul C. Grint | Director |
| Paul Grint, M.D. | Director |
| Andrew W. Miller | Director |
| John Morgan | Director |
| Hal Oien | Director |
| Diane Olmstead | Director |
| Kaveri Parker | Executive |
| Larry Shapiro | Director |
| William Weismann | Director, Executive |
| William P. Wiesmann | Director, Executive |
| William P. Wiesmann, M.D. | Director, Executive |